Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Broadridge To Benefit From FundsLibrary Buyout: Here's How

Published 03/03/2020, 07:08 AM
Updated 07/09/2023, 06:31 AM

Broadridge Financial Solutions, Inc. (NYSE:BR) yesterday announced that it has completed the acquisition of FundsLibrary — a leader in fund document and data dissemination in the European market — from Hargreaves Lansdown (LON:HRGV). The deal was initially announced on Jan 21, 2020. Financial terms have been kept under wraps.

Over the past year, shares of Broadridge have gained 6.6% against 1.2% decline of the industry it belongs and 4.9% rally of the Zacks S&P 500 composite.

Ramp Up of European Regulatory Communications Business

FundsLibrary will be merged with FundAssist, Broadridge's existing European funds regulatory communications business.

The union of FundsLibrary's data platform and technology with Broadridge's existing fund calculation, document creation and translation capabilities should help fund managers increase distribution opportunities and comply with both UK domestic and EU regulations such as Solvency II and MiFID II.

The combined entity will be known as Broadridge Fund Communication Solutions, and will be led by Arun Sarwal, former CEO of FundsLibrary.

Collectively, the buyout will amplify Broadridge's pan-European regulatory communications and digital data platform, supporting the lifecycle of fund data, documents, and regulatory reporting for the investment industry.

Considering the increasing demand for regulatory requirements across multiple jurisdictions, the deal seems to be a strategic move on Broadridge's part to strengthen its foothold in the global investment industry.

We also believe the move will help Broadridge strengthen its Investor Communication Solutions segment, which offers governance and communications solutions to banks/broker-dealers, asset management firms/mutual funds, corporate issuers and wealth management firms. Revenues from the segment decreased 2% year over year in second-quarter fiscal 2020.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank & Stocks to Consider

Currently, Broadridge carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the broader Zacks Business Services sector are Interpublic (NYSE:IPG) , Omnicom (NYSE:OMC) and Genpact (NYSE:G) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Long-term expected EPS (three to five years) growth rate for Interpublic, Omnicom and Genpact is 4.5%, 5.6% and 11.9%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Omnicom Group Inc. (OMC): Free Stock Analysis Report

Interpublic Group of Companies, Inc. (The) (IPG): Free Stock Analysis Report

Broadridge Financial Solutions, Inc. (BR): Free Stock Analysis Report

Genpact Limited (G): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.